MedPath

Shanghai Chest Hospital

Shanghai Chest Hospital logo
🇨🇳China
Ownership
-
Established
1957-01-01
Employees
-
Market Cap
-
Website
http://www.shmtppp.com/hospitals/chest

Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation

Not Applicable
Conditions
Persistent Atrial Fibrillation
Interventions
Procedure: Amiodarone hydrochloride tablet + acupoint catgut embedding
First Posted Date
2021-11-18
Last Posted Date
2021-11-18
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
120
Registration Number
NCT05125042

Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy

Phase 2
Not yet recruiting
Conditions
Esophageal Squamous Cell Carcinomas
Interventions
First Posted Date
2021-11-02
Last Posted Date
2021-11-02
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
54
Registration Number
NCT05103501

Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis.

Not Applicable
Not yet recruiting
Conditions
Persistent Atrial Fibrillation
Interventions
Procedure: Circumferential pulmonary vein isolation + linear ablation + bi-atrial mapping + driver ablation
Procedure: Circumferential pulmonary vein isolation + linear ablation + posterior wall box isolation
Procedure: Circumferential pulmonary vein isolation + linear ablation + vein of Marshall ethanol infusion
First Posted Date
2021-10-20
Last Posted Date
2021-10-20
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
300
Registration Number
NCT05085912

A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients

Phase 2
Conditions
NSCLC
Interventions
First Posted Date
2021-10-15
Last Posted Date
2021-12-08
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
35
Registration Number
NCT05078931
Locations
🇨🇳

Department of Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China

Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia

Not Applicable
Not yet recruiting
Conditions
Sinus Bradycardia
Interventions
Procedure: Pacemaker implantation
Procedure: Cardiac autonomic nerve modification
First Posted Date
2021-08-25
Last Posted Date
2021-08-25
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
240
Registration Number
NCT05021627

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.

Phase 2
Conditions
NSCLC
Interventions
First Posted Date
2021-08-13
Last Posted Date
2021-08-13
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
61
Registration Number
NCT05005468
Locations
🇨🇳

Shanghai Chest Hospital, Shanghai, Shanghai, China

To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

Not Applicable
Active, not recruiting
Conditions
Extensive-Stage Small-Cell Lung Cancer
Interventions
First Posted Date
2021-08-02
Last Posted Date
2023-12-01
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
90
Registration Number
NCT04985851
Locations
🇨🇳

Shanghai Chest Hospital, Shanghai, Shanghai, China

Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer

Conditions
Esophageal Cancer
First Posted Date
2021-07-30
Last Posted Date
2021-07-30
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
50
Registration Number
NCT04984096

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

Recruiting
Conditions
Non-Small Cell Lung Cancer
First Posted Date
2021-07-27
Last Posted Date
2025-05-22
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
250
Registration Number
NCT04977791
Locations
🇨🇳

Xiaomin Niu, Shanghai, Shanghai, China

Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients

Phase 1
Completed
Conditions
Non Small Cell Lung Cancer
Interventions
First Posted Date
2021-07-19
Last Posted Date
2024-04-23
Lead Sponsor
Shanghai Chest Hospital
Target Recruit Count
33
Registration Number
NCT04967079
Locations
🇨🇳

Shanghai Chest Hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath